• Ticker

    Advertisement Find a Broker - Visit the DailyFinance Broker Center
DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$39.81 $0.10 (0.25%)

Quote as of

Roche Holding Ltd. (ADR)

NASDAQOTH:RHHBY.PK

Jump to this page for:

Related Resources

Mylan launches generic version of Bonviva tablets in Italy and UK

5/24/2012 by Theflyonthewall.com

Leerinks' life science tools and medical devices analysts hold a conference call

5/24/2012 by Theflyonthewall.com

Sachs Associates to host a forum

5/21/2012 by Theflyonthewall.com

Ventana licenses Gen-Probe IP for measuring ERG protein

5/21/2012 by Theflyonthewall.com

Ventana licenses Gen-Probe IP for measuring ERG protein in prostate cancer patients

5/21/2012 by PR Newswire

GlaxoSmithKline has upside following melanoma data, says Citigroup

5/18/2012 by Theflyonthewall.com

ARUP Laboratories celebrates new state-of-the-art diagnostic technology with the VENTANA BenchMark Special Stains system

5/17/2012 by PR Newswire

Pfizer, Glaxo, J&J Grab ASCO Spotlight

5/16/2012 by TheStreet.com

Roche Alzheimer's drug to be tested on healthy people, NY Times says

5/16/2012 by Theflyonthewall.com

Genentech Will Report New Data on Important Progress for People with Advanced Cancers at ASCO 2012

5/16/2012 by Business Wire

Groundbreaking Alzheimer's Disease Prevention Trial Announced

5/15/2012 by PR Newswire

Amylin climbs after report says seven companies involved in sales process

5/15/2012 by Theflyonthewall.com

Anti-Obesity Drugs a Hot Topic in the Biotech Industry

5/14/2012 by Marketwire

Obesity: The Next Investment Driver

5/11/2012 by InvestorPlace

Bernstein to host a conference

5/10/2012 by Theflyonthewall.com

Roche initiated with a Buy at Societe Generale

5/10/2012 by Theflyonthewall.com

Roche ends development of dalcetrapib due to lack of efficacy

5/8/2012 by Theflyonthewall.com

Roche downgraded to Neutral from Overweight at JPMorgan

5/8/2012 by Theflyonthewall.com

The FDA Pediatric Advisory Committee to hold a meeting

5/7/2012 by Theflyonthewall.com

Accelrys to hold a user group meeting

5/7/2012 by Theflyonthewall.com

Curis announces collaborator Roche's submission of Erivedge with TGA

5/7/2012 by Theflyonthewall.com

Ventana receives FDA clearance for p53

5/7/2012 by Theflyonthewall.com

Roche ends "good cholesterol" drug development, WSJ reports

5/7/2012 by Theflyonthewall.com

Genentech reports positive study of ACTEMRA given by subcutaneous injection

5/3/2012 by Theflyonthewall.com

5 Stocks Hated by Hedge Funds

5/2/2012 by TheStreet.com

Roche decides not to extend its tender offer for Illumina, Inc.

4/18/2012 by Business Wire

Achillion Will Soar Higher On New Hepatitis C Drug In 2013

4/12/2012 by Seeking Alpha

Roche issues statement regarding Illumina offer

4/12/2012 by Business Wire

Roche disappointed with ISS recommendation

4/6/2012 by Business Wire

Roche sends second letter to Illumina shareholders

4/4/2012 by Business Wire

Roche disappointed by Illumina, Inc.’s Board of Directors’ rejection

4/3/2012 by Business Wire

Roche Receives FDA Approval for cobas p 630 Pre-analytical Solution for Automated Molecular Testing Platform

3/30/2012 by PR Newswire

Genentech’s Trastuzumab Emtansine (T-DM1) Showed Positive Phase III Results In HER2-Positive Metastatic Breast Cancer

3/30/2012 by Business Wire

Arena Pharmaceuticals Inc. Race to Bring First Weight Loss Drug to Market Since Roche Holding AG's Xenical in 1999

3/29/2012 by Marketwire

Roche increases offer price for Illumina shares to US$ 51.00 per share

3/29/2012 by Business Wire

Roche extends tender offer for Illumina

3/26/2012 by Business Wire

Roche files definitive proxy statement

3/20/2012 by Business Wire

The Generic Boniva Opportunity (RHHBY, MYL)

3/19/2012 by 24/7 Wall Street

Ventana Introduces the BenchMark Special Stains Platform

3/19/2012 by PR Newswire

New Professional Guidelines Recognize Benefit of Genotyping HPV 16 and 18 for Cervical Cancer Prevention by Assessing Individual Patient Risk

3/15/2012 by PR Newswire
See More Articles...